Search
for
Sort by
Research 961–990 of 1000+
- Referee report. For: Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic [version 2; peer review: 1 approved]
- Dermatological manifestations of Coronavirus Disease 2019 (COVID-19)
- Red nail bands in conjunction with telogen effluvium as a post‐COVID‐19 phenomenon
- Change in dermatology practice during crisis and normalization periods after the COVID-19 pandemic and potential problems awaiting us
- Another year in the grip of COVID‐19 with slow recovery
- Hair, Nail, and Skin Changes during COVID 19 Era
- 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Immune system response to the Covid 19 virus and 3rd boosters
- Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review
- BIOMEDICINA ESTÉTICA E AS CONTRIBUIÇÕES DO TRATAMENTO CONTRA QUEDA CAPILAR COM PLASMA RICO EM PLAQUETAS PÓS COVID-19.
- 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas
- Prevalence and Pattern of Skin Manifestations in COVID-19 Patients; A Cross-Sectional Observational Study in Saudi Arabia
- NATURAL ANTIVIRALS FOR THE MANAGEMENT OF SARS-COVID-19: A REVIEW
- 032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
- CAPILLARY DISEASES IN PATIENTS WHO HAD COVID-19
- Epidemiological profile of patients presenting to dermatology department of a tertiary care hospital during nationwide lockdown due to COVID-19: a retrospective study from north India
- Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Study of Paediatric Dermatology Consultations during COVID-19 Lockdown
- Impact of comorbidity burden on mortality in patients with COVID-19: a retrospective analysis of the Korean health insurance database
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- The effect of sex hormone on COVID-19: analysis of laboratory-confirmed 5061 patients in South Korea
- Use of Finasteride and Spironolactone in Hospitalized COVID-19 Patients and Their Effect on Severity Outcomes
- Occurrence and persistence of symptoms, diagnoses and prescriptions after community-diagnosed COVID-19: a matched cohort study using the OpenSAFELY platform
- Incidence and probable risk factors of post COVID syndrome among COVID-19 patients in urban population of North Kerala: a 6 months cohort study
- Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
- A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)